Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand

Wiener Klinische Wochenschrift, Supplement

Volumn 116, Issue 4 SUPPL., 2004, Pages 47-52

  Pirker Krassnig, Daniela K ^a   Wernsdorfer, Gunther ^b   Sirichaisinthop, Jeeraphat ^c   Rojanawatsirivet, Chaiporn ^c   Kollaritsch, Herwig ^a   Wernsdorfer, Walther H ^a,b,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

^d Div Specific Prophylaxis/Trop Med   (Austria)

Author keywords

Desbutyl benflumetol; Drug sensitivity; In vitro; Lumefantrine; Plasmodium vivax

Indexed keywords

BENFLUMETOL; CHLOROQUINE; DESBUTYLBENFLUMETOL; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG STRUCTURE; MULTIDRUG RESISTANCE; NONHUMAN; PARASITE ISOLATION; PLASMODIUM VIVAX; STATISTICAL ANALYSIS; THAILAND;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; CHI-SQUARE DISTRIBUTION; CHILD; CONFIDENCE INTERVALS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; THAILAND;

EID: 11244285196     PISSN: 03005178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Wernsdorfer G, Wernsdorfer WH (2003) Malaria at the turn from the 2nd to the 3rd millennium. Wien Klin Wochenschr 115 [Suppl 3]: 2-9
2. Miller LH (1988) Genetically determined human resistance factors. In: Wernsdorfer WH, McGregor IA (eds) Malaria. Principles and practice of malariology. Churchill Livingstone, Edinburgh, pp 487-500
3. Garnham PCC (1988) Malaria parasites of man: life-cycles and morphology (excluding ultrastructure). In: Wernsdorfer WH, McGregor IA (eds) Malaria. Principles and practice of malariology. Churchill Livingstone, Edinburgh, pp 61-96
4. Macdonald G (1953) Epidemiological basis of malaria control. Bull World Health Org 15: 613-626
5. World Health Organization (2001) The use of antimalarial drugs. Report of a WHO Informal Consultation. Document WHO/CDS/RBM/2001.33. WHO, Geneva
6. Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK (1989) A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report. Trans R Soc Trop Med Hyg 83: 607-608
7. Rieckmann KH, Davis DR, Halton DC (1989) Plasmodium vivax resistance to chloroquine? Lancet 2: 1183-1184
8. Collignon P (1991) Chloroquine resistance in Plasmodium vivax. J Infect Dis 164: 222-223
9. Murphy GS, Purnomo HB, Andersen EM, Bangs MJ, Mount DL, Corden J, Lal AA, Purwokusumo AR, Harjosuwarno S, Sorensen K, Hoffmann SI (1993) Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341: 96-100
10. Dua VK, Kar PK, Sharma VP (1992) Chloroquine resistant Plasmodium vivax in India. Trop Med Int Health 1: 816-819
11. Malar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing, Ma-Sabai, Myint-Oo (1995) Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg 89: 307-308
12. World Health Organization (2002) Monitoring antimalarial drug resistance. Report of a WHO Consultation. Document WHO/CDS/CSR/EPH/2002.17. WHO, Geneva
13. Tasanor O, Noedl H, Na-Bangchang K, Congpuong K, Sirichaisinthop J, Wernsdorfer WH (2002) An in vitro System for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Tropica 83: 49-61
14. World Health Organization (1990) Practical chemotherapy of malaria. Report of a WHO Scientific Group. WHO Tech Rep Ser 805. WHO, Geneva
15. Lux D, Prajakwong S, Kollaritsch H, Wernsdorfer G, Wernsdorfer WH (2003) In-vitro sensitivity testing of Plasmodium vivax: Response to lumefantrine and chloroquine in northwestern Thailand. Wien Klin Wochenschr 115 [Suppl 3]: 50-54
16. Lefèvre G, Thomsen MS (1999) Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Invest 18: 467-480
17. Wernsdorfer WH, Landgraf B, Kilimali VA, Wernsdorfer G (1998) Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. Acta Tropica 70: 9-15
18. Congpuong K, Na-Bangchang K, Thimasarn K, Tasanor U, Wernsdorfer WH (2002) Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. Acta Tropica 83: 117-121
19. Noedl H, Allmendinger TA, Prajakwong S, Wernsdorfer G, Wernsdorfer WH (2001) Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand. Antimicrob Agents Chemother 45: 2106-2109
20. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharm Exp Ther 96: 99-113
21. Wernsdorfer WH, Wernsdorfer MG (1995) The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum. Mitt Österr Ges Tropenmed Parasitol 17: 221-228
22. Brockelman CR, Tan-Ariya P, Bunnag D (1989) Development of an in vitro micro test for the assessment of Plasmodium vivax sensitivity to chloroquine. Southeast Asian J Trop Med Publ Hlth 20: 41-47
23. Wernsdorfer WH (2004) Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert Rev Anti-infect Ther 2: 181-196
24. + currents by antimalarial drugs in stably transfected HEK293 cells. Eur J Pharmacol 484: 41-48